Paysign, Inc. TPNL Income Statement

Paysign, inc. (TPNL)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenues
10,576	-	-	-	7,257	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenues
4,855	-	-	-	3,482	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenues
-	-	9,008	8,636	-	6,865	6,421	5,460	4,676	4,613	4,001	3,418	3,200	3,047	2,812	2,375	2,181	2,164	2,033	2,311	1,598	4,944	1,707	1,233	2,407	1,931	1,061	1,204	2,111	2,044	622	2,549	1,484	1,419	278	665	937	1,051	1,034
Cost of revenues
-	-	3,641	3,598	-	3,375	3,376	2,840	2,433	2,699	2,145	1,855	1,833	1,820	1,522	1,243	1,292	1,064	929	980	1,045	942	1,080	703	1,929	974	737	799	1,591	1,742	307	2,033	1,221	1,156	90	432	750	873	860
Gross profit
5,720	5,061	5,366	5,038	3,775	3,489	3,044	2,619	2,243	1,913	1,856	1,562	1,367	1,226	1,290	1,131	888	1,099	1,104	1,330	553	4,002	627	529	478	956	323	404	519	301	315	515	262	262	187	232	186	178	174
Operating expenses
Selling, general and administrative
3,827	3,172	2,765	3,012	2,704	2,591	1,996	1,667	1,579	1,208	1,104	928	814	549	660	682	713	768	1,270	786	907	1,082	543	580	508	517	390	300	268	271	191	143	153	120	129	144	152	132	124
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74	71	65	36	35	33	27	10	9	10	15	15	11	16	8	10	12	11	17	-
Depreciation and amortization
502	435	318	395	333	308	284	250	246	-	276	234	215	-	149	133	123	-	74	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35
Total operating expenses
4,329	-	-	-	3,038	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
-	-	3,084	3,408	-	-	2,281	1,918	1,825	1,358	1,380	1,162	1,029	715	809	816	837	910	1,345	861	979	1,147	580	616	542	544	400	310	278	287	207	155	170	129	140	157	164	150	159
Income from operations
1,391	1,453	2,282	1,629	736	589	763	701	418	554	475	399	337	511	480	315	51	189	-241	469	-426	2,854	47	-86	-64	411	-77	94	240	14	107	360	92	133	47	75	22	27	14
Other income (expense)
Gain on debt extinguishment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	11	0	0	0	0	-	-	-	-	-	23	1,136	-	-	0	0	-	-	-
Other expense
-	-	0	0	-	0	0	-3	-28	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
62	76	113	131	119	49	36	33	20	-	14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	5	20	5	4	2	3	-	-5	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Legal settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,500	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	0	31	-	18	20	22	15	20	4	4	16	93	16	16	15	14	14	14	14	14	16	15	15	16	15	15	15	16	16
Total other income, net
62	76	113	131	119	49	36	29	-7	15	14	-25	20	-13	-15	-20	-11	-21	-2,509	-4	-5	-93	-16	-16	-15	-14	-14	-14	-14	122	7	1,120	-15	-16	-15	-15	-15	-16	-16
Income before income tax benefit and noncontrolling interest
1,453	1,529	2,395	1,761	855	638	800	731	410	569	489	373	357	498	464	294	39	168	-2,750	465	-431	2,761	30	-102	-80	397	-92	79	226	136	114	1,480	76	117	31	59	6	11	-1
Income tax benefit
-87	-353	-563	23	-15	0	0	0	0	-3	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before noncontrolling interest
1,540	1,883	2,959	1,738	871	638	800	731	410	572	486	370	354	498	464	294	39	168	-2,750	465	-431	2,761	30	-102	-80	397	-92	79	226	136	114	1,480	76	117	31	59	6	11	0
Net loss attributable to the noncontrolling interest
0	-0	-0	-0	-0	-3	-0	-0	-1	35	-13	-13	-14	-4	-15	-40	-42	31	-138	-42	9	-0	-0	0	-0	-0	0	-0	-0	-11	2	-0	-0	-	-	-	-	-	-
Net loss attributable to the noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	-0	0	-0	-0	-1
Net income attributable to Paysign, Inc.
1,540	1,883	2,960	1,738	871	642	800	732	412	537	500	384	369	502	480	335	81	136	-2,612	507	-441	2,761	31	-102	-80	397	-92	79	226	147	112	1,480	76	117	31	59	6	11	-1
Net income per common share - basic
0.03	0.04	0.06	0.04	0.02	0.01	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.00	0.00	-0.06	0.01	-0.01	0.07	0.00	0.00	0.00	0.01	0.00	0.00	0.01	0.01	0.00	0.04	0.00	-	0.00	0.00	0.00	0.00	-
Net income per common share - fully diluted
0.03	0.04	0.05	0.03	0.02	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	-0.01	0.00	0.01	0.00	-	0.00	0.00	-	0.00	0.00	0.00	0.01	0.01	0.00	0.04	0.00	-	0.00	0.00	-	-	-
Net income per common share - basic and fully diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00
Weighted average common shares outstanding - basic
48,713	45,104	47,371	47,310	49,961	45,784	45,460	45,560	44,990	43,666	43,474	43,262	43,185	42,969	42,948	42,907	42,676	42,596	42,156	36,977	36,834	38,377	38,959	38,959	38,936	39,264	38,951	38,592	38,927	35,250	38,817	36,789	35,250	35,250	35,249	35,248	35,247	35,233	29,293
Weighted average common shares outstanding - fully diluted
54,688	54,433	54,291	54,967	54,508	52,861	52,215	51,988	50,880	59,255	44,544	44,189	44,159	46,555	43,138	43,098	42,676	-38,178	0	38,178	0	-	42,419	0	-	84,797	0	42,392	42,388	45,902	38,817	38,329	35,250	-	35,249	35,248	-	-	-
Plasma Industry [Member]
Revenues
7,343	-	-	-	5,884	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pharma industry [Member]
Revenues
3,020	-	-	-	1,372	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other [Member]
Revenues
212	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-